ENTOD Pharmaceuticals deny unethical or false presentation of facts to media on PresVu Eye Drops

Sep 06, 2024

The ENTOD Pharmaceuticals declared that they have not made any of the unethical or false presentation of facts to the media or public on...

"Unethical and false presentation of facts" by Entod Pharmaceuticals on PresVu eye drops say official sources

Sep 05, 2024

The ENTOD Pharmaceuticals claiming PresVU eye drops approved by DCGI offering spectacular treatment for Presbyopia, making with spectacles is unethical and false presentation, said...

Drug regulator suspends product PresVu over unauthorised promotion

Sep 11, 2024

The Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod Pharmaceuticals after the company failed to respond to...

Entod pharma to move court against DCGI's order suspending PresVu eye drop license

Sep 11, 2024

The drug regulator suspended permission, citing the company's failure to respond to the queries on the product for which the DCGI says "no approval...

ENTOD meets Drug Controller General of India, issues clarification for PresVu Eye Drops

Sep 26, 2024

Mumbai-based ENTOD Pharmaceuticals met with the Drug Controller General of India (DCGI) earlier this week to address concerns surrounding PresVu eye drops, which were...

Nikkhil K Masurkar Appointed as Vice Chairperson of IDMA's R&D and Innovation Committee

May 30, 2025

Mumbai (Maharashtra) [India], May 30: Nikkhil K Masurkar, CEO of Mumbai-based ENTOD Pharmaceuticals, has been appointed as the Vice Chairperson of the R&D and...